Filing Details

Accession Number:
0001209191-22-018095
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-10 21:00:16
Reporting Period:
2022-03-08
Accepted Time:
2022-03-10 21:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478320 Adaptive Biotechnologies Corp ADPT Biological Products, (No Disgnostic Substances) (2836) 270907024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799081 L Stacy Taylor C/O Adaptive Biotechnologies
1165 Eastlake Ave E
Seattle WA 98109
Svp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-08 2,387 $11.44 72,859 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
  2. The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.32 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.